Reporte zur Charge 4T8040NA

Symptomtext

pregnant patient who got the Fluzone with no reported adverse event; Initial information received on 25-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 30 years old female patient who was pregnant and got the influenza quadrival a-b vaccine [Fluzone Quadrivalent] with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported pregnant patient who got the Fluzone with no reported adverse event occurred at 30 weeks of pregnancy and the patient was exposed to influenza quadrival A-B vaccine at 30 weeks of pregnancy, during third pregnancy trimester for influenza quadrival A-B vaccine. The date of last menstrual period was reported as 27-Jan-2023. The estimated due date is 03-Nov-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 25-Aug-2023, the pregnant patient received a Dose 1 of suspect influenza quadrival A-B vaccine Suspension for injection (lot 4T8040NA) (with an unknown dosage, strength, expiry date) via intramuscular route in unknown administration site for prophylactic vaccination (Immunisation) with no reported adverse event (exposure during pregnancy) (latency- same day). Relevant prenatal testing after exposure was not reported. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. Additionally, at time of reporting, the pregnancy is still ongoing.